Traitement des carcinoses péritonéales d'origine colo-rectale. Quoi ...

Original Article
oxaliplatin for peritoneal carcinomatosis of colorectal origin.
J Clin Oncol. 2009;27:681-685.
14. Shen P, Thai K, Stewart JH, et al. Peritoneal surface disease
from colorectal cancer: comparison with the hepatic metastases
surgical paradigm in optimally resected patients. Ann
Surg Oncol. 2008;15:3422-3432.
15. Gilly FN, Carry PY, Sayag AC, et al. Regional chemotherapy
(with mitomycin C) and intra-operative hyperthermia
for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology.
1994;41:124-129.
16. Jacquet P, Sugarbaker PH. Clinical research methodologies
in diagnosis and staging of patients with peritoneal carcinomatosis.
Cancer Treat Res. 1996;82:359-374.
17. Sugarbaker PH, Chang D. Results of treatment of 385
patients with peritoneal surface spread of appendiceal malignancy.
Ann Surg Oncol. 1999;6:727-731.
18. Levine EA, Stewart JH, Russell GB, Geisinger KR, Loggie BL,
Shen P. Cytoreductive surgery and intraperitoneal hyperthermic
chemotherapy for peritoneal surface malignancy: experience
with 501 procedures. JAmCollSurg. 2007;204:943-953.
19. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab
plus irinotecan, fluorouracil, and leucovorin for metastatic
colorectal cancer. N Engl J Med. 2004;350:2335-2342.
20. Goldberg RM, Sargent DJ, Morton RF, et al. Randomized
controlled trial of reduced-dose bolus fluorouracil plus leucovorin
and irinotecan or infused fluorouracil plus leucovorin
and oxaliplatin in patients with previously untreated metastatic
colorectal cancer: a North American intergroup trial.
J Clin Oncol. 2006;24:3347-3353.
21. Moran BJ. Decision-making and technical factors account
for the learning curve in complex surgery. J Public Health
(Oxf). 2006;28:375-378.
22. Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve
of combined modality treatment in peritoneal surface disease.
Br J Surg. 2007;94:1408-1414.
23. Yan TD, Links M, Fransi S, et al. Learning curve for cytoreductive
surgery and perioperative intraperitoneal chemotherapy
for peritoneal surface malignancy—a journey to
becoming a nationally funded peritonectomy center. Ann
Surg Oncol. 2007;14:2270-2280.
24. Mohamed F, Moran BJ. Morbidity and mortality with
cytoreductive surgery and intraperitoneal chemotherapy: the
importance of a learning curve. Cancer J. 2009;15:196-199.
25. Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction
in 174 patients with peritoneal carcinomatosis
from appendiceal malignancy. Ann Surg. 2004;240:278-285.
5618 Cancer December 15, 2010